Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COR-1 in Heart Failure due to Dilated Cardiomyopathy
NCT01391507Phase 2Completed
- Sponsor
- Corimmun GmbH
- Start
- Oct 2011
- Primary completion
- Aug 2013
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Mibenratide in dilated cardiomyopathy (DCM), sponsored by Corimmun GmbH. Started Oct 2011; status: completed.
02
Drugs
Mibenratide
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT01391507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01391507.